Dexamethasone treatments prevent translocation of GLUT-4 to the cell surface via altering insulin signaling pathway by inhibiting phosphatidylinositol-3-kinase (PI3K) and serine/threonine protein kinase and induces insulin resistance. The gene discussed is SLC2A4; the disease is Insulin resistance.